BACE1 and Mental deterioration: • BACE inhibitors • To assess whether atabecestat slows cognitive decline compared to placebo, as measured by the Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive, asymptomatic Alzheimer’s risk participants.